Sheng et al. confirmed that lncRNA ST7-AS1 inhibits the progression of glioma through a p53/ST7-AS1/PTBP1 feedback loop, which might be a potential therapeutic target for glioma treatment [92]. This evidence concerns the gene TP53 and glioma.